Sonora Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sonora Investment Management's BMY Position: Q3 2021 in Review
Sonora Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q3 2021, selling an estimated $55.2K and leaving 6,536 shares worth $387K. The position accounts for 0.05% of the portfolio, ranked #150.
Sonora Investment Management first reported a position in BMY in Q3 2015 and has held it in 25 quarters since. The position peaked at $723K in Q3 2020. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Sonora Investment Management held 6,536 shares of Bristol-Myers Squibb worth $387K as of Q3 2021.
- Sonora Investment Management sold 838 Bristol-Myers Squibb shares in Q3 2021, an estimated $55.2K.
- Bristol-Myers Squibb made up 0.05% of Sonora Investment Management's portfolio in Q3 2021, its #150 holding.
- Sonora Investment Management first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 25 quarters since.
- Sonora Investment Management's Bristol-Myers Squibb position peaked at $723K in Q3 2020.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.